faculty

Marc Arbyn has diplomas of MD, MSc and Dr in tropical medicine.
After a career in Africa with Médecins Sans Frontières, he got involved in cancer research in Europe. MA coordinated the evaluation of new screening methods in the framework of the EU Network of Cervical Cancer Screening and is editor- of the European Guidelines for Cervical Cancer Screening and associated Supplements on HPV screening. His main activity deals with systematic reviews, Cochrane reviews and meta-analyses regarding cervical cancer screening, diagnosis and treatment of screen detected cervical cancer precursors and HPV vaccination. MA is steering group member or coordinator of several international networks involved in biobank-based cancer research that addresses etiological questions and possible application of biomarkers in screening, diagnosis and prognosis prediction and offers epidemiological support to health authorities of about twenty countries regarding implementation of cervical cancer prevention.
MA is author of ~200 papers, published in peer-reviewed journals. He has published in the following high-impact journals: Lancet, Lancet Oncol, JAMA, Nature, BMJ, J Natl Cancer Inst. He is first author of three Cochrane reviews (one completed on triage of women with minor abnormal cervical lesions and two on-going regarding prophylactic HPV vaccination and cervical cancer screening in developing countries). He is also co-author of two other Cochrane reviews on adverse effects associated with treatment of cervical precancer and on primary HPV-based versus cytology-based cervical screening. He is currently conducting an individual patient data meta-analysis on the correlation between the extension of excisional treatment of cervical precancer and the risk of preterm delivery in women who subsequently become pregnant.
MA is also specialised in trend analysis and age-cohort-period modelling.
MA is coordinator of the Unit of Cancer Epidemiology, which is part of the Belgian Cancer Centre at the Scientific Institute of Public Health in Brussels.
A restricted list of publications of the last five years is included in annex.